Models Based on Dynamic Clinicopathological Indices for Predicting Prognosis During the Perioperative Period for Patients with Colorectal Cancer

Yifei Ma1 Department of Gastrointestinal Oncology Surgery, Hubei Cancer Hospital, The Seventh Clinical School Affiliated of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of ChinaView further author information

Ping Lu2 Department of Abdominal Oncology, Hubei Cancer Hospital, The Seventh Clinical School Affiliated of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of ChinaView further author information

Xinjun Liang2 Department of Abdominal Oncology, Hubei Cancer Hospital, The Seventh Clinical School Affiliated of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of ChinaCorrespondence[email protected]

https://orcid.org/0000-0002-5180-7926 View further author information

Shaozhong Wei1 Department of Gastrointestinal Oncology Surgery, Hubei Cancer Hospital, The Seventh Clinical School Affiliated of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of ChinaCorrespondence[email protected]
View further author information

Pages 1591-1601 | Published online: 21 Apr 2021

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

References

Siegel RL, Miller KD, Goding SA, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145–164. doi:10.3322/caac.21601
PubMed Web of Science ®Google Scholar
Weitz J, Koch M, Debus J, Höhler T, Galle PR, Büchler MW Colorectal cancer. Lancet. 2005;365(9454):153–165. (). doi:10.1016/S0140-6736(05)17706-X
PubMed Web of Science ®Google Scholar
Balkwill F, Mantovani A Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255):539–545. (). doi:10.1016/S0140-6736(00)04046-0
PubMed Web of Science ®Google Scholar
Murata M. Inflammation and cancer. Environ Health Prev Med. 2018;23(1):50. doi:10.1186/s12199-018-0740-1
PubMed Web of Science ®Google Scholar
de Visser KE, Eichten A, Coussens LM Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. 2006;6(1):24–37. (). doi:10.1038/nrc1782
PubMed Web of Science ®Google Scholar
Jamieson NB, Glen P, McMillan DC Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas. Br J Cancer. 2005;92(1):21–23. (). doi:10.1038/sj.bjc.6602305
PubMed Web of Science ®Google Scholar
Lamb GW, McArdle PA. The connection between the local and systemic inflammatory responses and survival in patients undergoing resection for localized renal cancer. BJU Int. 2008;102(6):756–761. doi:10.1111/j.1464-410X.2008.07666.x
PubMed Web of Science ®Google Scholar
Ogino S, Nosho K, Irahara N. Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype. Clin Cancer Res. 2009;15(20):6412–6420. doi:10.1158/1078-0432.CCR-09-1438
PubMed Web of Science ®Google Scholar
Rozek LS, Schmit SL, Greenson JK. Tumor-infiltrating lymphocytes, crohn’s-like lymphoid reaction, and survival from colorectal cancer. J Natl Cancer Inst. 2016;108(8):. doi:10.1093/jnci/djw027
PubMedGoogle Scholar
Hu X, Li YQ, Ma X-J, Zhang L, Cai S-J, Peng -J-J. A Risk Signature With Inflammatory and T Immune Cells Infiltration in Colorectal Cancer Predicting Distant Metastases and Efficiency of Chemotherapy. Front Oncol. 2019;9:704. doi:10.3389/fonc.2019.00704
PubMed Web of Science ®Google Scholar
Gryfe R, Kim H, Hsieh ETK Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med. 2000;342(2):69–77. (). doi:10.1056/NEJM200001133420201
PubMed Web of Science ®Google Scholar
Hutchins G, Southward K, Handley K. Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer. J Clin Oncol. 2011;29(10):1261–1270. doi:10.1200/JCO.2010.30.1366
PubMed Web of Science ®Google Scholar
Pine JK, Morris E. Systemic neutrophil-to-lymphocyte ratio in colorectal cancer: the connection to patient survival, tumour biology and local lymphocytic response to tumour. Br J Cancer. 2015;113(2):204–211. doi:10.1038/bjc.2015.87
PubMed Web of Science ®Google Scholar
Haram A. The prognostic value of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review. J Surg Oncol. 2017;9999:1–10.
Google Scholar
Dolan RD, Lim J, McSorley ST, Horgan PG, McMillan DC. The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: systematic review and meta-analysis. Sci Rep. 2017;7:16717.
PubMed Web of Science ®Google Scholar
Ya X, Wenbin F, Wenfeng Y. Perioperative changes of inflammation-based biomarker for predicting the prognosis in colorectal cancer patients: a retrospective analysis. Prz Gastroenterol. 2019;14(4):258–267. doi:10.5114/pg.2019.90252
PubMed Web of Science ®Google Scholar
Ashizawa N, Furuya S. Clinical significance of dynamic neutrophil-lymphocyte ratio changes in patients with colorectal cancer. Anticancer Res. 2020;40(4):2311–2317. doi:10.21873/anticanres.14197
PubMed Web of Science ®Google Scholar
You W, Yan L, Cai Z, et al. Clinical significances of positive postoperative serum CEA and Post-preoperative CEA Increment in Stage II and III Colorectal Cancer: a Multicenter Retrospective Study. Front Oncol. 2020;10:671. doi:10.3389/fonc.2020.00671
PubMed Web of Science ®Google Scholar
Vacante M, Ciuni R, Basile F, Biondi A. The Liquid Biopsy in the Management of Colorectal Cancer: an Overview. Biomedicines. 2020;8(9):308. doi:10.3390/biomedicines8090308
PubMed Web of Science ®Google Scholar
Vacante M, Borzì AM, Basile F, Biondi A. Biomarkers in colorectal cancer: current clinical utility and future perspectives. World J Clin Cases. 2018;6(15):869–881. doi:10.12998/wjcc.v6.i15.869
PubMed Web of Science ®Google Scholar
Fujino S, Myoshi N. The inflammation-nutrition score supports the prognostic prediction of the TNM stage for colorectal cancer patients after curative resection. Surg Today. 2020;50(2):163–170. doi:10.1007/s00595-019-01861-2
PubMed Web of Science ®Google Scholar
Okugawa Y, Toiyama Y, Yamamoto A. Lymphocyte-C-reactive protein ratio as promising new marker for predicting surgical and oncological outcomes in colorectal cancer. Ann Surg. 2020;272(2):342–351. doi:10.1097/SLA.0000000000003239
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Models Based on Dynamic Clinicopathological Indices for Predicting Prognosis During the Perioperative Period for Patients with Colorectal Cancer

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Models Based on Dynamic Clinicopathological Indices for Predicting Prognosis During the Perioperative Period for Patients with Colorectal Cancer

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date